BTN3A1

BTN3A1 Molekülinformation

Englischer Name	Butyrophilin subfamily 3 member A1	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	1	Target-Alias	BTF5，BTN3A1，CD_antigen，BTN3.1，BT3.1，DJ45P21.3 (Butyrophilin， Subfamily 3， Member A1)，Butyrophilin， Subfamily 3， Member A1，CD277 Antigen
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

Englischer Name	Butyrophilin subfamily 3 member A1
Target-Alias	BTF5，BTN3A1，CD_antigen，BTN3.1，BT3.1，DJ45P21.3 (Butyrophilin， Subfamily 3， Member A1)，Butyrophilin， Subfamily 3， Member A1，CD277 Antigen
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	1
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

BTN3A1 Produktliste

Attribut
Protein (3)
Produktbibliothek
Online (3)
Spezies
Human (3)
Etikett
Fc Tag (1)His Tag & Avi Tag (1)His Tag (1)
Marker
Unconjugated (2)Biotin-labeled (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Vorbestellen/Bestellen
HOT BT1-H5255	Human	HEK293	Human BTN3A1 / CD277 Protein, Fc Tag (MALS verified)	In den Warenkorb legen
HOT BT1-H52H4	Human	HEK293	Human BTN3A1 / CD277 Protein, His Tag, active dimer, low endotoxin (MALS verified)	In den Warenkorb legen
HOT BT1-H82E4	Human	HEK293	Biotinylated Human BTN3A1 / CD277 Protein, His,Avitag™	In den Warenkorb legen

Gesamtmenge3

BTN3A1 Molekülhintergrund

Butyrophilin subfamily 3 member A1 (BTN3A1) is also known as CD277 and BTF5, which belongs to the immunoglobulin superfamily and contains one B30.2/SPRY domain and two Ig-like V-type (immunoglobulin-like) domains. BTN3A1 plays a role in T-cell activation and in the adaptive immune response. Also, BTN3A1 regulates the proliferation of activated T-cells and the release of cytokines and IFNG by activated T-cells. Furthermore, BTN3A1 mediates the response of T-cells toward infected and transformed cells that are characterized by high levels of phosphorylated metabolites, such as isopentenyl pyrophosphate.